Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Central Nervous System Neoplasm”

597 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 597 results

Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Testing effectiveness (Phase 2)UnknownNCT00492687
What this trial is testing

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
San Diego Pacific Oncology & Hematology Associates 80
Not applicableStudy completedNCT04919993
What this trial is testing

CBT for Insomnia in Primary Brain Tumor Patients

Who this might be right for
Primary Brain TumorPBT
Virginia Commonwealth University 44
Testing effectiveness (Phase 2)Looking for participantsNCT05278208
What this trial is testing

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Who this might be right for
High Grade GliomaMeningiomaEmbryonal Tumor+10 more
Nationwide Children's Hospital 65
Testing effectiveness (Phase 2)Study completedNCT01083316
What this trial is testing

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00062478
What this trial is testing

Study of Karenitecin (BNP1350) in Patients With Brain Tumors

Who this might be right for
Brain NeoplasmsMalignant Neoplasms, BrainBrain Tumors
BioNumerik Pharmaceuticals, Inc. 40
Early research (Phase 1)Study completedNCT04456140
What this trial is testing

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Who this might be right for
Breast CarcinomaDigestive System NeoplasmMalignant Brain Neoplasm+8 more
Mayo Clinic 230
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Not applicableEnded earlyNCT00504218
What this trial is testing

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
HypopituitarismHypogonadismThyroid Dysfunction+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 62
Early research (Phase 1)Ended earlyNCT03558750
What this trial is testing

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Who this might be right for
Recurrent Central Nervous System LymphomaRecurrent Diffuse Large B-Cell LymphomaRefractory Central Nervous System Lymphoma+1 more
Vanderbilt-Ingram Cancer Center 6
Early research (Phase 1)UnknownNCT00083096
What this trial is testing

Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 30
Large-scale testing (Phase 3)Study completedNCT06057168
What this trial is testing

Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas

Who this might be right for
Brain Tumor, PrimaryBrain Tumor, Recurrent
Guerbet 138
Early research (Phase 1)Study completedNCT00002824
What this trial is testing

Gene Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT07015242
What this trial is testing

The Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 65
Not applicableActive Not RecruitingNCT05023434
What this trial is testing

Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors

Who this might be right for
Brain TumorBrain CancerMotor Cortex; Lesion
Medical College of Wisconsin 60
Not applicableLooking for participantsNCT05108298
What this trial is testing

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Who this might be right for
Breast Cancer, NOSCNS Primary Tumor, NOSCervical Cancer, NOS+9 more
Eastern Cooperative Oncology Group 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00784914
What this trial is testing

A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
City of Hope Medical Center 12
Load More Results